Vaccine Adjuvants: Selection Criteria, Mechanism of Action Associated with Immune Responses and Future Directions.
Arslan Habib, Khalid Mahmood Anjum, Riffat Iqbal, Ghulam Jaffar, Zeeshan Ashraf, Malik Shahzaib Khalid, Muhammad Usman Taj, Syeda Wafa Zainab 等 11 位
Fudan University State Key Laboratory of Genetic Engineering
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
The most effective method to minimize the prevalence of infectious diseases is vaccination. Vaccines enhance immunity and provide protection against different kinds of infections. Subunit vaccines are safe and less toxic, but due to their lower immunogenicity, they need adjuvants to boost the immune system. Adjuvants are small particles/molecules integrated into a vaccine to enhance the immunogenic feedback of antigens. They play a significant role to enhance the potency and efficiency of vaccines. There are several types of adjuvants with different mechanisms of action; therefore, improved knowledge of their immunogenicity will help develop a new generation of adjuvants. Many trials have been designed using different kinds of vaccine adjuvants to examine their safety and efficacy, but in practice, only a few have entered in animal and human clinical trials. However, for the development of safe and effective vaccines, it is important to have adequate knowledge of the side effects and toxicity of different adjuvants. The current review discussed the adjuvants which are available for producing modern vaccines as well as some new classes of adjuvants in clinical trials.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Immunotherapy and Immune Responses
SARS-CoV-2 and COVID-19 Research · vaccines and immunoinformatics approaches
参考文献 0
引用本文 11
按被引量排序,此处列出前 3 条